Current status of immune checkpoint inhibition in early stage NSCLC.
暂无分享,去创建一个
D. de Ruysscher | D. Ruysscher | S. Peters | J. Vansteenkiste | B. Reymen | E. Wauters | C. Ackermann | Solange Peters
暂无分享,去创建一个
D. de Ruysscher | D. Ruysscher | S. Peters | J. Vansteenkiste | B. Reymen | E. Wauters | C. Ackermann | Solange Peters